Answers are grounded in this paper and cite their sources.
Evaluates systemic toxicity of titanium implant extracts in Swiss albino mice, suggesting safety for orthopedic use.
Titanium-based implants are widely used in orthopedic surgery due to their strength, corrosion resistance, and favorable biocompatibility profile. However, before clinical application, implants must undergo biological safety testing to evaluate potential adverse effects. The present study assessed the acute systemic toxicity of polar and non-polar extracts prepared from a titanium orthopedic implant in Swiss albino mice, following the requirements of ISO 10993-11 and ISO 10993-12. Extracts were prepared using 0.9% sodium chloride (polar medium) and cottonseed oil (non-polar medium) at 37°C for 71 hours. A single dose of 50 mL/kg body weight was administered intravenously (IV) for polar extracts and intraperitoneally (IP) for non-polar extracts. Animals were observed for clinical signs, mortality, and body weight changes over 72 hours. No mortality, abnormal clinical signs, or significant body weight loss were observed in any test or control group. All animals showed normal behavior and progressive weight gain. The results indicate that the titanium implant extracts did not produce acute systemic toxicity under the study conditions and meet the acceptance criteria specified in ISO 10993-11. These findings support the biological safety of the tested titanium implant for orthopedic applications.
No takes yet. Share an insight, caveat, or question.
Rakesh Kumar (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: